Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Marksans Pharma

BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 20, 15:44
25.50
0.15 (0.59%)
VOLUME 119,830
LIVE
NSE
Jul 20, 15:54
25.60
0.15 (0.59%)
VOLUME 764,830
Announcements on Marksans Pharma

22nd-May-2018 16:03Source: BSE

Marksans Pharma- Board Meeting-Closure of Trading Window

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and approve the Annual Audited Financial Results of the...

22nd-May-2018 16:00Source: BSE

Marksans Pharma- Board Meeting - Board Meeting On Wednesday, 30Th May, 2018


This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and approve the Annual Audited Financial Results of the...

10th-Apr-2018 10:21Source: BSE

Marksans Pharma- Compliance Certificate For The Period Ended 31.03.2018

Reg. 7(3) RTA Compliance Certificate for the period ended 31.03.2018

10th-Apr-2018 10:16Source: BSE

Marksans Pharma- Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complai...

14th-Mar-2018 15:13Source: BSE

Marksans Pharma- Announcement under Regulation 30 (LODR)-Change in Directorate

Appointment of Mr. Digant Mahesh Parikh as Independent Director

12th-Feb-2018 13:04Source: NSE

Marksans Pharma Limited

Marksans Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

12th-Feb-2018 12:42Source: BSE

Marksans Pharma- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release dated 12.02.2018

12th-Feb-2018 12:36Source: BSE

Marksans Pharma- Board Meeting-Outcome of Board Meeting

Sub: Unaudited Financial Results for the quarter ended 31st December, 2017 and Limited Review Reports thereon.

Dear Sir,

In terms of Regulation 33 of the SEBI (Listing Obligation an...

2nd-Feb-2018 15:48Source: BSE

Marksans Pharma- Closure of Trading Window

Dear Sir,

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 12th February, 2018 at Mumbai, to consider and approve the Unaudited Financi...

2nd-Feb-2018 15:42Source: BSE

Marksans Pharma- Board Meeting On 12.02.2018

Board Meeting on 12.02.2018

1 2 3 4 5 Next >>
Quick Links for Marksans Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.